LETTER
Synthesis of Highly Substituted Imidazole Derivatives
1685
0 °C for 1 h. The mixture was quenched with sat. aq NH4Cl
solution (3 mL) and extracted with CH2Cl2 (3 × 30 mL). The
combined organic phases were dried over Na2SO4 and the
crude product was purified by column chromatography
(silica gel, hexane–EtOAc = 4:1), which provided 50 mg
(50%) of 7a as yellow crystals.
References and Notes
(1) Reviews: (a) Zimmer, R.; Reissig, H.-U. Modern Allene
Chemistry, Vol. 2; Krause, N.; Hashmi, A. S. K., Eds.;
Wiley-VCH: Weinheim, 2004, 847–876. (b) Reissig, H.-U.;
Hormuth, S.; Schade, W.; Okala Amombo, M. G.;
Watanabe, T.; Pulz, R.; Hausherr, A.; Zimmer, R. J.
Heterocycl. Chem. 2000, 37, 597 . Original publications:
(c) Okala Amombo, M. G.; Hausherr, A.; Reissig, H.-U.
Synlett 1999, 1871. (d) Flögel, O.; Reissig, H.-U. Synlett
2004, 895.
(2) (a) Synthesis of the g-amino acid (–)-detoxinine: Flögel, O.;
Okala Amombo, M. G.; Reissig, H.-U.; Zahn, G.; Brüdgam,
I.; Hartl, H. Chem. Eur. J. 2003, 9, 1405. (b) Synthesis of
(–)-preussin: Hausherr, A. Dissertation; Freie Universität
Berlin: Berlin, 2002. (c) Synthesis of both enantiomers of
anisomycin: Kaden, S.; Brockmann, M.; Reissig, H.-U.
Helv. Chem. Acta 2005, 88, 1826. (d) Synthesis of
codonopsinine: Chowdhury, M. A.; Reissig, H.-U.
manuscript in preparation for Synlett.
Analytical Data for 4-Ethynyl-2-methyl-1,5-
diphenylimidazole (7a).
Mp 163–164 °C. 1H NMR (500 MHz, CDCl3): d = 2.28 (s,
3 H, Me), 3.07 (s, 1 H, ≡CH), 7.09–7.41 (m, 10 H, Ph) ppm.
13C NMR (126 MHz, CDCl3): d = 14.2 (q, Me), 78.3 (s, ≡C),
78.4 (d, H–C≡), 127.7, 127.8, 128.2, 128.9, 129.0, 129.7 (6
d, Ph), 128.8, 137.2 (2 s, Ph), 120.3 (s, C-4), 136.6 (s, C-5),
146.0 (s, C-2) ppm. IR (KBr): 3290–2850 (C-H), 2105
(C≡C), 1595 (C=C) cm–1. MS (EI, 80 eV, 40 °C): m/z (%) =
258 (71) [M]+, 216 (30), 181 (5) [M – C6H5]+, 114 (23), 91
(25), 77 (55) [C6H5]+, 51 (28), 28 (100). HRMS (EI, 80 eV,
40 °C): m/z calcd for C18H14N2: 258.1157. Found: 258.1163.
(6) Typical Procedure for Sonogashira Reaction 7a → 8a.
To a solution of Et3N (0.8 mL) and DMF (0.4 mL) under Ar
were added iodobenzene (0.08 mL, 0.69 mmol), alkyne 7a
(150 mg, 0.58 mmol), PdCl2(PPh3)2 (18 mg, 0.025 mmol),
and CuI (2 mg, 0.012 mmol). The mixture was stirred at r.t.
for 16 h, then quenched with sat. aq NH4Cl solution (3 mL)
and extracted with CH2Cl2 (3 × 30 mL). The combined
organic phases were dried over Na2SO4 and the resulting
crude product was purified by column chromatography
(silica gel, toluene–EtOAc = 4:1) to give 150 mg (77%) of
8a as pale yellow crystals.
(3) For a review of the Ritter reaction, see: Krimen, L. I.; Cota,
D. J. Org. React. 1969, 17, 213.
(4) Typical Procedure for the Preparation of Imidazole 6a.
A solution of methoxyallene (2.80 g, 39.9 mmol) in dry THF
(50 mL) under Ar was treated at –40 °C with n-BuLi (2.5 M
in hexane, 14.4 mL, 35.9 mmol, deprotonation time 5–10
min). Imine 2a (5.10 g, 28.1 mmol) dissolved in dry THF (10
mL) was added within 5 min. The mixture was stirred for 2
h at –20 °C and quenched with H2O (100 mL). Warm up to
r.t. was followed by extraction with Et2O (3 × 100 mL),
drying (Na2SO4), and concentration in vacuo, which led to
crude product 3a, yield 7.00 g (99%).
Analytical Data for 4-Phenylethynyl-2-methyl-1,5-
diphenylimidazole (8a).
Mp 189–190 °C. 1H NMR (500 MHz, CDCl3): d = 2.30 (s,
3 H, Me), 7.11–7.46 (m, 15 H, Ph) ppm. 13C NMR (126
MHz, CDCl3): d = 14.2 (q, Me), 84.3 (s, ≡C), 90.4 (s, Ph-
C≡), 127.7, 127.8, 127.9, 128.2, 128.3, 128.8, 128.9, 129.6,
131.4 (9 d, Ph), 121.4 (s, C-4), 123.7, 129.1, 136.8 (3 s, Ph),
136.4 (s, C-5), 146.3 (s, C-2) ppm. IR (KBr): 3055–2855
(=CH, CH), 2570 (C≡C), 1600 (C=C) cm–1. MS (EI, 80 eV,
40 °C): m/z (%) = 335 (31), 334 (100) [M]+, 333 (32), 292
(29), 291 (32), 189 (27), 167 (17), 145 (23), 139 (12), 126
(11), 125 (16), 123 (22), 105 (19), 91 (13), 57 (13). HRMS
(EI, 80 eV, 40 °C): m/z calcd for C24H18N2: 334.1470.
Found: 334.1464.
Iodine (2.54 g, 10.0 mmol) was dissolved in freshly distilled
MeCN (50 mL) at 45 °C and stirred for 10 min. A solution
of crude allenyl amine 3a (1.00 g, 3.98 mmol) dissolved in
MeCN (10 mL) was added within 5 min and the mixture was
stirred for 15 h at r.t. 10% Na2S2O3 solution (30 mL) was
added and the mixture was extracted with CH2Cl2 (3 × 50
mL), dried over Na2SO4 and concentrated in vacuo
furnishing crude 5a (1.95 g).
Crude 5a was dissolved in dry CH2Cl2 (4 mL) under Ar, and
CF3SO3H (0.5 mL, 5.59 mmol) was added dropwise. The
mixture was stirred for 1 h at r.t., treated with dilute
NaHCO3 solution (30 mL), then with 10% Na2S2O3 solution
(10 mL) and extracted with CH2Cl2 (3 × 50 mL). The
combined organic phases were washed with H2O (1 × 30
mL) and dried over Na2SO4. The crude product was purified
by column chromatography (silica gel, hexane–
(7) (a) Zhu, J.; Bienaymé, H. Multicomponent Reactions;
Wiley-VCH: Weinheim, 2005. (b) Dömling, A. Chem. Rev.
2006, 106, 17. (c) Zhu, J. Eur. J. Org. Chem. 2003, 1133.
(d) Dömling, A.; Ugi, I. Angew. Chem. Int. Ed. 2000, 39,
3168; Angew. Chem. 2000, 112, 3300.
(8) For an interesting alternative approach to highly substituted
imidazoles, which employs a dilithiated allene derivative
and nitriles, see: Langer, P.; Döring, M.; Seyferth, D.; Görls,
H. Eur. J. Org. Chem. 2003, 1948.
EtOAc = 4:1) to yield 1.22 g (80% overall yield) of 6a as
yellow crystals.
Analytical Data for 4-(1-Iodoethenyl)-2-methyl-1,5-
diphenylimidazole (6a).
Mp 104–105 °C. 1H NMR (500 MHz, CDCl3): d = 2.30 (s,
3 H, Me), 5.96, 6.14 (2 d, J = 1.4 Hz, each 1 H, =CH2), 7.07–
7.36 (m, 10 H, Ph) ppm. 13C NMR (126 MHz, CDCl3):
d = 14.1 (q, Me), 98.9 (s, =C–I), 127.8, 127.9, 128.3, 128.7,
129.4, 130.5 (6 d, Ph), 128.9 (t, =CH2), 129.1 (s, Ph), 129.8
(s, C-5), 136.5 (s, Ph), 138.0 (s, C-4), 144.4 (s, C-2) ppm. IR
(KBr): 3185–2870 (=CH, CH), 1600 (C=C) cm–1. MS (EI,
80 eV, 40 °C): m/z (%) = 386 (17) [M]+, 259 (100) [M – I]+,
218 (50), 184 (18), 77 (26) [C6H5]+, 43 (21), 28 (13). HRMS
(EI, 80 eV, 40 °C): m/z calcd for C18H15IN2: 386.0280.
Found: 386.0267.
(9) (a) Reviews: Grimmett, M. R. Comprehensive Heterocyclic
Chemistry, Vol. 5; Katritzky, A. R.; Rees, C. W., Eds.;
Pergamon Press: London, 1984, 374–498. (b) Grimmet, M.
R. Comprehensive Heterocyclic Chemistry II, Vol. 3;
Katritzky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.;
Pergamon Press: Oxford, 1996, 77–220. Selected original
publications: (c) Applications in medicinal chemistry:
Lambardino, J. G.; Wiesman, E. H. J. Med. Chem. 1974, 17,
1182. (d) Tsujii, S.; Rinehart, K. L. J. Org. Chem. 1988, 53,
5446. (e) Sakemi, S.; Sun, H. H. J. Org. Chem. 1991, 56,
4304. (f) Lee, J. C.; Laydon, J. T.; McDonnel, P. C.;
Gallagher, T. F.; Kumar, S.; Green, D.; McNulty, D.;
Blumenthal, M. J.; Heys, J. R.; Landvatter, S. W.; Strickler,
J. E.; Mclaughlin, M. M.; Siemens, I. R.; Fisher, S. M.; Livi,
G. P.; White, J. R.; Adams, J. L.; Young, P. R. Nature
(5) Typical Procedure for the Preparation of Alkyne 7a.
To a solution of imidazole 6a (152 mg, 0.39 mmol) in dry
THF (2 mL) was added at 0 °C dropwise a solution of
potassium tert-butoxide (88 mg, 0.78 mmol) in THF (1 mL).
The flask was flushed with Ar, sealed and allowed to stir at
Synlett 2006, No. 11, 1683–1686 © Thieme Stuttgart · New York